Part D Outreach to Medical Specialty Groups and Long Term Care Associations

To Medicare Part D Plans:

In order to help simplify the process of Part D plans and pharmacists determining whether a drug should be billed to Part D or Part B, we have sent the attached letters to Medical specialty groups (see the attached list) in the areas of oncology, hematology, transplants, and rheumatology, and to long-term care associations.

These letters recommend that providers include certain additional information on prescriptions that may help Part D plans and pharmacists differentiate between those drugs filled by pharmacies which may qualify as Part D drugs and those which may qualify as Part B drugs. The inclusion of additional information on the prescription by the provider is entirely voluntary. The information would be intended to facilitate, but not replace, your existing processes for making a determination of Part D coverage.

We thank you for your partnership in the Part D program.